EarlySight aims to reduce vision loss by enabling efficient detection and better monitoring of eye diseases. The company develops a high-performance eye imaging instrument empowering doctors to see the first disease impacts. Our technology allows to visualize the morphology of many cells in the retina that are playing key roles in the disease degenerative process and that were invisible to ophthalmic instruments before. According to ophthalmologists, it will greatly improve the detection and monitoring of many diseases such as age-related macular degeneration. It will also provide quantitative evidence of treatment efficacy and speed up the development of new therapies. With EarlySight technology, assessing the retina state of health and monitoring treatment effects can be done non-invasively in only few seconds, without having to wait months for visual acuity changes.
